Skip to main content
Download PDF

DNA methylation status of nuclear-encoded mitochondrial genes underlies the tissue-dependent mitochondrial functions

BMC Genomics volume 11, Article number: 481 (2010) Cite this article

Abstract

Background

Mitochondria are semi-autonomous, semi-self-replicating organelles harboring their own DNA (mitochondrial DNA, mtDNA), and their dysregulation is involved in the development of various diseases. While mtDNA does not generally undergo epigenetic modifications, almost all mitochondrial proteins are encoded by nuclear DNA. However, the epigenetic regulation of nuclear-encoded mitochondrial genes (nuclear mt genes) has not been comprehensively analyzed.

Results

We analyzed the DNA methylation status of 899 nuclear mt genes in the liver, brain, and heart tissues of mouse, and identified 636 nuclear mt genes carrying tissue-dependent and differentially methylated regions (T-DMRs). These nuclar mt genes are involved in various mitochondrial functions and they also include genes related to human diseases. T-DMRs regulate the expression of nuclear mt genes. Nuclear mt genes with tissue-specific hypomethylated T-DMRs were characterized by enrichment of the target genes of specific transcription factors such as FOXA2 in the liver, and CEBPA and STAT1 in the brain.

Conclusions

A substantial proportion of nuclear mt genes contained T-DMRs, and the DNA methylation status of numerous T-DMRs should underlie tissue-dependent mitochondrial functions.

Background

Mitochondrial dysfunction is a common cause of human diseases [1, 2], and thus understanding the regulation of mitochondrial functions is critical. Mitochondria do not contain histones [3], and almost all mtDNA is unmethylated [4, 5], indicating that mtDNA is not epigenetically regulated. However, while mammalian mitochondria are estimated to consist of more than 1,500 proteins, only 13 proteins are encoded by mtDNA.

Methylation of nuclear DNA is a major component of epigenetic system in mammalian cells, and is involved in silencing of gene transcription and maintaining genomic stability [6, 7]. Hypomethylation of regulatory regions is required to allow expression of genes [8, 9]. Microarray-based DNA methylation analysis revealed the existence of thousands of tissue-dependent and differentially methylated regions (T-DMRs) in the mouse and human genomes [10, 11]. While the T-DMRs of some genes, such as Oct-4 and Nanog, are hypomethylated only in a few cells [12, 13], the methylation status of most T-DMRs is not specific, but common to certain cells or tissues [11, 14]. Tissue-dependent methylation status of T-DMRs, including tissue-specific methylation status of T-DMRs, forms a distinctive DNA methylation profile for each cell type [8, 11, 15].

A nuclear mt gene, Ant4, which encodes mitochondrial outer membrane protein, contains T-DMRs which is specifically hypomethylated in the testis [16, 17]. Also, few dozens of nuclear mt genes in mice are hypomethylated in the liver relative to the cerebrum [11]. However, the presence of T-DMRs in nuclear mt genes has not been comprehensively analyzed; this is necessary for understanding the regulation of mitochondrial functions. In this study, we analyzed the DNA methylation of 899 nuclear mt genes in the liver, brain, and heart tissues of mouse; these tissues consume large amounts of energy and are highly susceptible to mitochondrial dysfunctions. Our results indicated that at least 636 nuclear mt genes, which account for 71% of the total investigated nuclear mt genes, contain T-DMRs in their transcription start site (TSS) flanking regions (-7~+3 kb of TSSs), and that the differential methylation status of these T-DMRs is associated with tissue-dependent mitochondrial functions.

Results and Discussion

Identification of T-DMRs in the TSS flanking regions of nuclear mt genes in the liver, brain, and heart tissues

To investigate the DNA methylation status of nuclear mt genes in the liver, brain (cerebrum), and heart tissues, we conducted pairwise tissue comparisons using model-based analysis of tiling-array (MAT) along with D-REAM analysis [11, 18]. Differences in the DNA methylation status at HpyCH4IV sites (ACGT sites) were exhibited as differences in MATscores of the probes corresponding to the selectively amplified fragments generated by digestion of unmethylated HpyCH4IV sites [11]. We identified tissue-dependent and differentially methylated HpyCH4IV sites within the 10 kb-TSS flanking regions of 899 RefSeq genes that are known to encode mitochondrial proteins and are registered in the Mitop2 database as a reference set [19]. In each tissue comparison, HpyCH4IV sites with MATscores above a specific threshold value were identified as hypomethylated T-DMRs in that particular tissue. The lowest MATscore of HpyCH4IV sites whose hypomethylation were confirmed by combined bisulfite restriction analysis (COBRA) (Figure 1A,B and Additional file 1,2), were considered as the threshold values of MATscore. COBRA was performed for HpyCH4IV sites whose MATscores were larger than 2 when one tissue was compared to the either of the other 2 tissues. We identified T-DMRs in the 10 kb-TSS flanking regions of 636 nuclear mt genes (Figure 1C and Additional file 3), with 123, 119, and 99 nuclear mt genes with T-DMRs specifically hypomethylated in the liver, brain, and heart tissues, respectively, when compared with the other 2 tissues (hereafter referred to as tissue-hypo T-DMRs) (Figure 1C and Additional file 4).

Figure 1
figure1

Nuclear mt genes with T-DMRs identified by D-REAM analysis. (A) Differential methylation levels of HpyCH4IV sites for which the relative hypomethylation levels were analyzed using the D-REAM analysis. For each HpyCH4IV site, the corresponding MATscore is indicated along the horizontal axis. In each tissue comparison, the lowest MATscore of the HpyCH4IV sites whose hypomethylation were confirmed using COBRA, was considered as a threshold value for detecting hypomethylated regions in the tissue comparison. Pale-colored circles indicate that the corresponding HpyCH4IV site was not included in the hypo T-DMRs (see text for definition). (B) Matrices show the differential level of DNA methylation of the liver-, brain-, and heart-hypo T-DMRs in the tissues relative to the respcective methylation level of hypo T-DMRs in the liver, brain, and heart, respectively. Each column represents a different hypo T-DMR. The names of nuclear mt genes containing hypo T-DMRs in their TSS flanking regions are displayed under each column. (C) Number of nuclear mt genes with T-DMRs. Matrix columns represent different nuclear mt genes. (D) Function of nuclear mt genes, nuclear mt genes with T-DMRs and nuclear mt genes with liver-hypo T-DMRs. Pie charts illustrate the percentage of genes that possess the indicated functions.

Full size image

Most functional categories of mitochondria classified by Mitop2 were found in nuclear mt genes with T-DMRs and with hypo T-DMRs (Figure 1D). Overrepresentation and underrepresentation of nuclear mt genes with liver-hypo T-DMRs were found in the detoxification and mitochondrial ribosomal categories, respectively (P < 0.05, Fisher's exact test; Figure 1D and Table 1). Detoxification is one of the functions of the liver. Nuclear mt genes with liver-hypo T-DMRs also included the genes related to liver-specific functions, namely, Otc and Lrpprc (Table 1). OTC functions in the urea cycle in the liver [20]. LRPPRC is a binding partner of PPARGC1A, and functions in hepatic gluconeogenesis [21]. Nuclear mt genes with T-DMRs contained a number of genes involved in various types of mitochondrial regulation, such as the regulation of protein sorting, mitochondrial morphology, and translation of mtDNA-encoded proteins (Table 1).

Table 1 Nuclear mt genes with hypo T-DMRs
Full size table

Human homologs of mouse nuclear mt genes possessing T-DMRs are related to various human diseases. For example, mutations of Lrpprc, Ndufs4, and Ndufs8, the genes with liver-, brain-, and heart-hypo T-DMRs, respectively, are associated with Leigh's disease [21–23]. In addition to mutations, overexpression of some nuclear mt genes with liver-hypo T-DMRs in non-liver tissues are involved in the human diseases. For example, overexpression of Acsl5 and Tgm2 are found in the human glioma and brain of Huntington's disease and are suggested to be involved in pathogenesis [24, 25].

Correlation between the DNA methylation status of T-DMRs and nuclear mt gene expression

Next, we examined the correlation between the DNA methylation status of nuclear mt genes and their expression using microarray data downloaded from Gene Expression Omnibus (Figure 2A and Additional file 5). The liver-hypo T-DMRs positively correlated with the liver vs. cerebral cortex and liver vs. heart expression ratios (Figure 2A). In the brain and heart, only the hypo T-DMRs located downstream of TSSs positively correlated with the ratio of the expression in hypomethylated tissue vs. other tissue (Figure 2A and Additional file 5). On the other hand, negative correlation was observed between the upstream heart-hypo T-DMRs and the heart vs. cerebral cortex expression ratio, although the average expression levels were greater in the heart (Figure 2A). Thus, the downstream hypo T-DMRs correlated with the expression of the nuclear mt genes in all tissues examined. The correlation between T-DMRs around TSSs and tissue-specific gene expression coincided with that in the previous reports [11, 15, 26, 27]. We confirmed the tissue-dependent gene expression of Otc, Acsl6, and Ndufs4, the genes carrying downstream hypo T-DMRs for liver, brain, and heart, respectively, by using real-time PCR (Figure 2B).

Figure 2
figure2

Expression of nuclear mt genes with hypo T-DMRs. (A) Boxplots show the expression ratio (log2 ratio) of the nuclear mt genes. Tissues used for comparisons are shown under the plots. "All" indicates that the plot shows the expression ratio of entire nuclear mt genes. "U" and "D" indicate that the plot shows the expression ratio of nuclear mt genes with hypo T-DMRs in upstream regions and downstream regions, respectively. The number of probe sets representing the expression levels of corresponding genes are displayed under the plot. P-values obtained from the Wilcoxon test are indicated on the top of the plot. (B) Genes which were relatively highly expressed in the tissues where downstream T-DMRs were hypomethylated, according to gene expression array data. Relative gene expression was confirmed using real-time PCR and was normalized to the expression of ß-actin (Actb). Bar graphs show the results of real-time PCR. "ND" indicates that the expression was not detected under the experimental condition used. Experiments were performed in biological duplicates, and all amplification were performed in triplicates. Error bars show standard deviations. For the Otc and Acsl6 genes, methylation levels of downstream hypo T-DMRs were examined by COBRA, and the electrophoresis images obtained by MultiNA microchip electrophoresis system are shown.

Full size image

Concentration of liver-hypo T-DMRs in the downstream regions of nuclear mt genes

In addition to the highest correlation of downstream liver-hypo T-DMRs with nuclear mt gene expression (Figure 2A and Additional file 5), a significantly larger proportion of the nuclear mt genes with liver-hypo T-DMRs contained these hypo T-DMRs in their downstream regions as compared to the nuclear mt genes with brain- and heart-hypo T-DMRs (P < 5 × 10-3, Fisher's exact test; Figure 3A). Furthermore, in genes with downstream liver-hypo T-DMRs, the nuclear mt genes were highly enriched (Figure 3B). Liver-hypo T-DMRs were especially enriched within regions of +1~+2 kb of TSSs of nuclear mt genes (Figure 3C). These results indicate that regulation of nuclear mt genes is especially dependent on DNA methylation in the liver.

Figure 3
figure3

Concentration of liver-hypo T-DMRs in downstream regions of nuclear mt genes. (A) Bar graphs show the ratio of genes with downstream hypo T-DMRs in nuclear mt genes with hypo T-DMRs. (B) Bar graphs show the ratio of nuclear mt genes in all genes and genes with hypo T-DMRs. (C) The vertical axis of the histograms indicate the average number of liver-hypo T-DMRs per gene. Gene sets represented in histograms are indicated on the top-left of each graph.

Full size image

Overrepresented transcriptional regulatory motifs in nuclear mt genes with liver- and brain-hypo T-DMRs

We next investigated whether T-DMRs of nuclear mt genes are associated with any transcriptional regulatory motifs. FOXA2 is a transcription factor that activates the genes involved in mitochondrial β-oxidation and the regulation of lipid metabolism, ketogenesis, and insulin sensitivity in the mouse liver [28, 29]. We analyzed the enrichment of genes containing FOXA2-binding sites within an extended gene region (encompassing 10 kb upstream of TSS and 1 kb downstream of the 3' UTR) using known genome-wide FOXA2-binding sites in the mouse liver obtained by ChIP-sequencing [30]. We found that the targets of FOXA2 were enriched 1.6-fold in nuclear mt genes with liver-hypo T-DMRs relative to all nuclear mt genes (P < 5 × 10-5, Fisher's exact test). Sixty-four out of 123 nuclear mt genes with liver-hypo T-DMRs were the targets of FOXA2 (Additional file 6). This is contrast to the previous report, which indicated enrichment of target genes of HNF1 and/or HNF4 in hypomethylated genes in the mouse liver [11].

We further analyzed the enrichment of specific regulatory motifs in nuclear mt genes with hypo T-DMRs by using the oPOSSUM program [31]. We used all nuclear mt genes as a background gene set, and analyzed both 5 kb upstream and downstream of TSSs of the genes with hypo T-DMRs. The enrichment of the genes with FOXA2-binding sites in their downstream region was observed in the nuclear mt genes with liver-hypo T-DMRs. (Table 2 and Additional file 7). It has been reported that FOXA2-binding at distal downstream region of TSS of CEBPA gene functions as an enhancer in humans [32]. Hypomethylation of downstream T-DMRs may enhance transcription by permitting transcription factors access to target genes. We also found that genes with NFYA-binding sites in their downstream regions were enriched among the nuclear mt genes with liver-hypo T-DMRs, and the genes with CEBPA- and STAT1-binding sites in their upstream regions were enriched among the nuclear mt genes with brain-hypo T-DMRs (Table 2 and Additional file 7). These results indicate that T-DMRs are associated with specific transcription factors in a tissue-dependent manner. CEBPA and STAT1 are reported to be involved in cortical neurogenesis [33] and inflammatory responses in the brain [34], respectively. It has been reported that CEBPA-null mice showed decreased nuclear mt gene expression in brown adipose tissue [35]. STAT1 also regulates nuclear mt gene expression in T cells in response to IFN-γ [36]. Hypomethylation of hypo T-DMRs of targets of these transcription factors may permit transcription factors access to the target genes, and hypermethylation of these T-DMRs may be essential for secured repression of the corresponding genes in other tissues.

Table 2 Transcription factors whose binding-sites were enriched in analyzed sequences
Full size table

Conclusion

At least 71% of investigated nuclear mt genes contains T-DMRs, and the methylation status of T-DMRs correlated with tissue-dependent expression of dozens of nuclear mt genes. Considering that there are at least 200 different cell types in the mammalian body, the total number of nuclear mt genes with T-DMRs will be higher. The differences in protein composition of mitochondria are reported to reflect tissue-dependent nuclear mt gene expression [37]. Our data suggest that DNA methylation status of nuclear mt genes underlies tissue-dependent mitochondrial functions.

Methods

Mice

C57BL/6N male mice were obtained from Charles River Japan. Mice were euthanized at 12-13 week old, and tissues were collected and frozen at -80°C until use. All experiments using mice were carried out according to the institutional guidelines for the care and use of laboratory animals (Graduate School of Agriculture and Life Sciences, The University of Tokyo).

Genomic DNA extraction

Genomic DNA was extracted as described previously [11]. Briefly, tissue samples were homogenized, and incubated with lysis solution (10 mM Tris-HCl at pH 8.0, 5 mM EDTA, 200 mM NaCl, 0.2% SDS, and 200 μg/mL proteinase K) at 55°C for 30 min, and were extracted with a phenol/chloroform/isoamylalcohol (PCI) mixture (50 : 49 : 1), incubated with RNase for 30 min, and re-extracted with PCI. DNA was precipitated with ethanol and dissolved in Tris-EDTA (TE) buffer (pH 8.0).

D-REAM analysis

We used T-DMR profiling with restriction-tag mediated amplification (D-REAM) analysis [11] to obtain tissue-dependent and differentially methylated HpyCH4IV sites within the TSS flanking regions of RefSeq genes. For D-REAM analysis, HpyCH4IV-digested genomic DNA was extracted with PCI, re-extracted with chloroform, precipitated with ethanol and dissolved in TE (pH 8.0). Using purified DNA (250 ng), following procedure of D-REAM analysis was performed as described previously [11]. Briefly, genomic DNA was digested by the methyl-sensitive enzyme HpyCH4IV (New England Biolabs), followed by ligation-mediated PCR, and subsequent hybridization of DNA to a GeneChip Mouse Promoter 1.0R Array (Affymetrix). Comparison of the resulting signals from digested HpyCH4IV sites between different tissue samples indicates the differential methylation level at a given site.

D-REAM analysis was performed twice for each of the biological duplicates of heart, and once for the liver and brain in this study. For the liver and brain, we added single D-REAM data set from our previous study using tissues from different individual [11]. Correlation coefficients of microarray probe intensities between biological duplicates were greater than 0.93. D-REAM data obtained in this study has been deposited in the ArrayExpress database (accession number A-MEXP-791).

Combined bisulfite restriction analysis (COBRA)

Genomic DNA was digested with HindIII (Takara). Digested DNA (5 μg) was denatured with 0.3 M NaOH. Sodium metabisulfite (pH 5.0) and hydroquinone were added to a final concentration of 2.0 M and 0.5 mM, respectively. The reaction mixture was incubated under following conditions: 15 cycles of 95°C for 30 s and 50°C for 15 min. Next, 1.77 volume of QG buffer was added to the reaction mixture, and DNA was purified using a Quiagen gel extraction kit (Qiagen), and eluted with 100 μl of elution buffer (EB). DNA was treated with 0.3 M NaOH at 37°C for 15 min, precipitated using 6 M ammonium acetate (pH 7.0) and ethanol, and dissolved in 200 μl TE (pH 8.0). For each bisulfite PCR, 2 μl of DNA solution was used as the template, and BIOTAQ HS DNA polymerase (Bioline) was used for amplification. PCR was performed under the following conditions: denaturation at 95°C for 10 min followed by 43 cycles, each cycle comprising 95°C for 30 sec, 60°C for 45 sec, 72°C for 30 sec, followed by 10 min at 72°C. All primers used in this experiment are listed in Additional file 2. The PCR product was digested with HpyCH4IV. Restriction-enzyme-treated DNA was desalted using gel filtration through Sephadex G-50, and was analyzed using the MultiNA microchip electrophoresis system (Shimadzu). The methylation level was calculated as the ratio of the amounts of cut fragments to those of the total of cut and uncut fragments obtained from the electropherograms.

RNA extraction, reverse transcription, and real-time PCR

Total RNA was prepared using TRIzol reagent (Invitrogen). Before synthesis of first-strand cDNA, the RNA preparation was treated with RNase-free DNase I (Invitrogen) to eliminate any residual genomic DNA. The total RNA was then converted into first-strand cDNA using random hexamers and Superscript III First-Strand Synthesis System for RT-PCR (Invitrogen). The obtained cDNA were amplified and quantified in triplicates by using the Quantitect SYBR Green PCR Kit (Qiagen) with ABI 7500 Real Time PCR system (Applied Biosystems). PCR was performed under the following conditions: Incubation at 95°C for 10 min followed by 40 cycles of PCR, each cycle comprising 95°C for 15 sec and 60°C for 1 min. All primers used in this experiment are listed in Additional file 8. Standard curves were obtained with serial dilutions of a pool of cDNA samples derived from each tissue.

Bioinformatics

MAT [18] was used to analyze the tiling array data (.CEL files) and identify the hypomethylated regions based on tiling probe signals, probe sequences, and copy numbers. Original tiling probes were remapped to the mouse genome assembly version mm9 (July 2007 build) provided by UCSC genome database. For the quality control of D-REAM analysis, we monitored the selective amplification of HpyCH4IV-digested fragments for the tilling array data of each sample (Additional file 9).

For expression analysis, data from the GeneChip Mouse Genome 430 2.0 Array of liver, heart, and cerebral cortex tissues of C57BL/6N male mice (8-10 week old; n = 2 for each tissue) were downloaded from Gene Expression Omnibus (accession no. GSE10246). The array image data (.CEL files) was processed by the factor analysis for robust microarray summarization algorithm (FARMS) with quantile normalization [38].

Enrichment analysis of specific transcription factor targets was performed using oPOSSUM program [31]. This program analyzed the genes using one-to-one human-mouse orthologs and detected promoter motifs in the conserved regions. The top 10% of the non-coding conserved regions with an absolute minimum percent identity of 70% in each 5 kb region upstream and downstream of the TSSs were analyzed for vertebrate promoter motifs with a matrix match threshold of 75%.

References

  1. 1.

    Enns GM: The contribution of mitochondria to common disorders. Mol. Genet. Metab. 2003, 80: 11-26. 10.1016/j.ymgme.2003.08.009.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Schapira AHV: Mitochondrial disease. Lancet. 2006, 368: 70-82. 10.1016/S0140-6736(06)68970-8.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Caron F, Jacq C, Rouvière-Yaniv J: Characterization of a histone-like protein extracted from yeast mitochondria. Proc. Natl. Acad. Sci. USA. 1979, 76: 4265-4269. 10.1073/pnas.76.9.4265.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  4. 4.

    Dawid IB: 5-methylcytidylic acid: absence from mitochondrial DNA of frogs and HeLa cells. Science. 1974, 184: 80-81. 10.1126/science.184.4132.80.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Groot GS, Kroon AM: Mitochondrial DNA from various organisms does not contain internally methylated cytosine in -CCGG- sequences. Biochim. Biophys. Acta. 1979, 564: 355-357.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Chen T, Li E: Structure and function of eukaryotic DNA methyltransferases. Curr. Top. Dev. Biol. 2004, 60: 55-89. full_text.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31: 89-97. 10.1016/j.tibs.2005.12.008.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Shiota K: DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res. 2004, 105: 325-334. 10.1159/000078205.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Lieb JD, Beck S, Bulyk ML, Farnham P, Hattori N, Henikoff S, Liu XS, Okumura K, Shiota K, Ushijima T, Greally JM: Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenet Genome Res. 2006, 114: 1-15. 10.1159/000091922.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  10. 10.

    Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Gräf S, Tomazou EM, Bäckdahl L, Johnson N, Herberth M, Howe KL, Jackson DK, Miretti MM, Fiegler H, Marioni JC, Birney E, Hubbard TJP, Carter NP, Tavaré S, Beck S: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008, 18: 1518-1529. 10.1101/gr.077479.108.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  11. 11.

    Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K: DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res. 2008, 18: 1969-1978. 10.1101/gr.074070.107.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  12. 12.

    Hattori N, Nishino K, Ko Y, Hattori N, Ohgane J, Tanaka S, Shiota K: Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 2004, 279: 17063-17069. 10.1074/jbc.M309002200.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Hattori N, Imao Y, Nishino K, Hattori N, Ohgane J, Yagi S, Tanaka S, Shiota K: Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells. 2007, 12: 387-396. 10.1111/j.1365-2443.2007.01058.x.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N: Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells. 2002, 7: 961-969. 10.1046/j.1365-2443.2002.00574.x.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Sato S, Yagi S, Arai Y, Hirabayashi K, Hattori N, Iwatani M, Okita K, Ohgane J, Tanaka S, Wakayama T, Yamanaka S, Shiota K: Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells. 2010, 15: 607-618. 10.1111/j.1365-2443.2010.01404.x.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Rodić N, Oka M, Hamazaki T, Murawski MR, Jorgensen M, Maatouk DM, Resnick JL, Li E, Terada N: DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells. 2005, 23: 1314-1323. 10.1634/stemcells.2005-0119.

    PubMed  Article  Google Scholar 

  17. 17.

    Suzuki M, Sato S, Arai Y, Shinohara T, Tanaka S, Greally JM, Hattori N, Shiota K: A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse. Genes Cells. 2007, 12: 1305-1314. 10.1111/j.1365-2443.2007.01136.x.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, Liu XS: Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. USA. 2006, 103: 12457-12462. 10.1073/pnas.0601180103.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  19. 19.

    Elstner M, Andreoli C, Ahting U, Tetko I, Klopstock T, Meitinger T, Prokisch H: MitoP2: an integrative tool for the analysis of the mitochondrial proteome. Mol. Biotechnol. 2008, 40: 306-315. 10.1007/s12033-008-9100-5.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Raijman L: Citrulline synthesis in rat tissues and liver content of carbamoyl phosphate and ornithine. Biochem. J. 1974, 138: 225-232.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  21. 21.

    Cooper MP, Qu L, Rohas LM, Lin J, Yang W, Erdjument-Bromage H, Tempst P, Spiegelman BM: Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. Genes Dev. 2006, 20: 2996-3009. 10.1101/gad.1483906.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  22. 22.

    Petruzzella V, Vergari R, Puzziferri I, Boffoli D, Lamantea E, Zeviani M, Papa S: A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. Hum. Mol. Genet. 2001, 10: 529-535. 10.1093/hmg/10.5.529.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Procaccio V, Wallace DC: Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations. Neurology. 2004, 62: 1899-1901.

    PubMed Central  PubMed  Article  Google Scholar 

  24. 24.

    Yamashita Y, Kumabe T, Cho YY, Watanabe M, Kawagishi J, Yoshimoto T, Fujino T, Kang MJ, Yamamoto TT: Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Oncogene. 2000, 19: 5919-5925. 10.1038/sj.onc.1203981.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Zainelli GM, Dudek NL, Ross CA, Kim S, Muma NA: Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J. Neuropathol. Exp. Neurol. 2005, 64: 58-65.

    CAS  PubMed  Google Scholar 

  26. 26.

    Imai S, Kikuchi R, Kusuhara H, Yagi S, Shiota K, Sugiyama Y: Analysis of DNA methylation and histone modification profiles of liver-specific transporters. Mol. Pharmacol. 2009, 75: 568-576. 10.1124/mol.108.052589.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Kikuchi R, Yagi S, Kusuhara H, Imai S, Sugiyama Y, Shiota K: Genome-wide analysis of epigenetic signatures for kidney-specific transporters. Kidney Int.

  28. 28.

    Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M: Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 2004, 432: 1027-1032. 10.1038/nature03047.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Wolfrum C, Stoffel M: Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 2006, 3: 99-110. 10.1016/j.cmet.2006.01.001.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Wederell ED, Bilenky M, Cullum R, Thiessen N, Dagpinar M, Delaney A, Varhol R, Zhao Y, Zeng T, Bernier B, Ingham M, Hirst M, Robertson G, Marra MA, Jones S, Hoodless PA: Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res. 2008, 36: 4549-4564. 10.1093/nar/gkn382.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  31. 31.

    Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, Kennedy BP, Wasserman WW: oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res. 2005, 33: 3154-3164. 10.1093/nar/gki624.

    PubMed Central  PubMed  Article  Google Scholar 

  32. 32.

    Miura H, Tomaru Y, Nakanishi M, Kondo S, Hayashizaki Y, Suzuki M: Identification of DNA regions and a set of transcriptional regulatory factors involved in transcriptional regulation of several human liver-enriched transcription factor genes. Nucleic Acids Res. 2009, 37: 778-792. 10.1093/nar/gkn978.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  33. 33.

    Ménard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabé-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD: An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron. 2002, 36: 597-610. 10.1016/S0896-6273(02)01026-7.

    PubMed  Article  Google Scholar 

  34. 34.

    Wang J, Schreiber RD, Campbell IL: STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc. Natl. Acad. Sci. USA. 2002, 99: 16209-16214. 10.1073/pnas.252454799.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  35. 35.

    Carmona MC, Iglesias R, Obregón M, Darlington GJ, Villarroya F, Giralt M: Mitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 2002, 277: 21489-21498. 10.1074/jbc.M201710200.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Jang J, Lee C: Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell. Immunol. 2003, 226: 11-19. 10.1016/j.cellimm.2003.11.004.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES, Mann M: Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell. 2003, 115: 629-640. 10.1016/S0092-8674(03)00926-7.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Hochreiter S, Clevert D, Obermayer K: A new summarization method for Affymetrix probe level data. Bioinformatics. 2006, 22: 943-949. 10.1093/bioinformatics/btl033.

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

This research was funded by grants from the National Institute of Biomedical Innovation (NIBIO); Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The authors declare no conflicts of interest. We would like to thank Dr. Shinya Sato and Mr. Hiroki Muramoto for their helpful suggestions regarding bioinformatic analysis.

Author information

Affiliations

  1. Laboratory of Cellular Biochemistry, Department of Animal Resource Science/Veterinary Medical Sciences, the University of Tolyo, Tokyo, 113-8657, Japan

    Masaki Takasugi, Shintaro Yagi, Keiji Hirabayashi & Kunio Shiota

  2. National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, 305-8561, Japan

    Kunio Shiota

Authors
  1. Masaki Takasugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shintaro Yagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keiji Hirabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kunio Shiota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kunio Shiota.

Additional information

Authors' contributions

MT and KS designed this study. KH performed D-REAM. MT performed COBRA and data analysis with help of SY, and wrote the paper with SY and KS. All authors read and approved the final manuscript.

Electronic supplementary material

Additional file 1: Figure S1 Differential methylation levels of HpyCH4IV sites and the corresponding MATscores. (PDF 282 KB)

Additional file 2: Table S1 Primers used for COBRA, and the result of the experiment. (XLS 30 KB)

Additional file 3: Table S2 Genomic locations of T-DMRs. (XLS 415 KB)

Additional file 4: Table S3 Genomic locations of hypo T-DMRs. (XLS 103 KB)

Additional file 5: FIgure S2 Expression ratio of nuclear mt genes with hypo T-DMRs. (PDF 328 KB)

Additional file 6: Table S4 Genes with liver-hypo T-DMRs and FOXA2-binding sites. (XLS 40 KB)

Additional file 7: Table S5 Genes with hypo T-DMRs and overrepresented transcription factor binding sites. (XLS 66 KB)

Additional file 8: Table S6 Primers used for real-time PCR. (XLS 16 KB)

Additional file 9: Figure S3 Distribution of MATscores calculated from D-REAM data of each tissue. (PDF 290 KB)

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Takasugi, M., Yagi, S., Hirabayashi, K. et al. DNA methylation status of nuclear-encoded mitochondrial genes underlies the tissue-dependent mitochondrial functions. BMC Genomics 11, 481 (2010). https://doi.org/10.1186/1471-2164-11-481

Download citation

Keywords

  • Methylation Status
  • Specific Transcription Factor
  • Sodium Metabisulfite
  • GeneChip Mouse
  • Combine Bisulfite Restriction Analysis

BMC Genomics

ISSN: 1471-2164

Contact us